Skip to main content

Table 1 Patient characteristics and clinical data

From: Evaluation of penehyclidine for prevention of post operative nausea and vomitting in patients undergoing total thyroidectomy under total intravenous anaesthesia with propofol-remifentanil

 

Penehyclidine (n = 50)

TIVA (n = 50)

P value

Age (yr)

42.8 ± 9.6

43.6 ± 10.1

0.590

Gender (M/F)

13/37

17/33

0.762

Body weight (kg)

64.5 ± 11.2

65.3 ± 11.7

0.674

Body height (cm)

165.3 ± 6.9

163.8 ± 7.5

0.473

Duration of surgery (min)

76.6 ± 13.9

75.5 ± 15.5

0.171

Duration of anesthesia (min)

95.9 ± 14.5

95.9 ± 16.7

0.104

Fentanyl consumption (mg)

0.41 ± 0.05

0.42 ± 0.06

0.492

Remifentanil consumption (μg)

580.4 ± 135.9

581.8 ± 129.8

0.431

  1. TIVA Propofol-based total intravenous anesthesia. Values are expressed as mean ± SD or ratio. There was no significant difference between two groups